Product Development Update (7599W)
25 November 2010 - 6:00PM
UK Regulatory
TIDMMST
RNS Number : 7599W
Mid-States PLC
25 November 2010
MID-STATES PLC (the "Company")
Development of the AD Miniature
The Company is pleased to announce that, as part of developing
the commercial potential of its flagship Air Disinfection product,
known as the 'AD', it has made good progress in developing a
miniature 'AD' device specifically designed for the retail market.
Development began on the AD miniature in January 2010 and the
Company can now report that:
-- Independent laboratory results from the University of Wales
Institute in Cardiff of the initial testing of the miniaturised air
disinfection prototype are very positive and show the small device
was equally as effective as the current AD device in reducing
bacteria (Staphylococcus aureus - MRSA) in a test chamber with a
volume of approximately 20 cubic metres (4.6 metres long x 2.2
meters high x 2.0 meters wide). Whilst further testing is required,
this is a key stage in the development of the product and
demonstrates the efficacy of the new device in a small room.
-- A patent covering the miniaturised air disinfection device
has been applied for in the UK and, under the terms of the Paris
Convention*, further applications can now be filed by the Company
in all other major territories during the next twelve months.
Javier Segura, Managing Director of Mid-States PLC, commented:
"We are delighted with the progress made with the development of
the miniaturised device. We believe there are multiple environments
to which the miniature AD is suited, for example the 'home health'
market, which could be very significant. Along with continuing to
further demonstrate the efficacy of the miniaturised device, we are
actively looking for the right partner to assist us in addressing
these large markets."
*Please note the Paris Convention is a treaty adhered to by
about 130 countries, which helps those who wish to obtain patent
protection in more than one country as this treaty allows patent
applicants a period of 12 months from their first filing (in their
home country) to file subsequent applications in other countries
for the same invention.
For further information:
Mid-States PLC Tel: +44 (0) 20 7603 1515
Andrew Tonks, Finance Director
Panmure Gordon (UK) Limited Tel: +44 (0) 20 7459 3600
Andrew Godber
Cardew Group Tel: +44 (0) 20 7930 0777
Tim Robertson / Catherine Maitland
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCBIBATMBTTBLM
Mid-states (LSE:MST)
Historical Stock Chart
From Aug 2024 to Sep 2024
Mid-states (LSE:MST)
Historical Stock Chart
From Sep 2023 to Sep 2024